Realty Income: Don't Be Fooled By Discount Valuations
Realty Income has held up well amid the broader market selloff since my initiating coverage. Read why I remain neutral on O ...
U.S. stocks are bouncing back. But these 5 charts suggest the selloff isn’t over yet.
Despite a strong start to the week, one longtime strategist doubts stocks will swiftly return to record territory. Instead, ...
KNG: A Defensive Covered Call ETF To Navigate Market Uncertainty (Rating Upgrade)
KNG ETF has a generous 9% starting dividend yield, with distributions paid monthly. Click here to read why KNG is upgraded to ...
The stock market is riding an oversold rally for now. Here’s where it could end.
The S&P 500 index is trying to rebound from severely oversold conditions. The most recent low was near 5,500, but there were ...
Schaeffer's Investment Research6 天
Gilead Sciences Stock Slips on Possible HIV Funding Cut
Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is ...
Schaeffer's Investment Research6 天
Goldman Sachs Stock Dips After Analyst Downgrade
On the charts, GS has dropped 16.6% over the past month, pressured by its 10-day moving average. Though it boasts a 41.7% year-over-year gain, it's down 3.8% in 2025, after falling from its Feb. 18 ...